Ribi Immunochem (ribi) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ribi Immunochem (ribi)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bill Green who wrote (83)	7/29/1998 1:04:00 PM
From: tom jones	of 92

To all: I talked to Ribi today about the preferred and more. I don't know if this is all correct. The institutional investor is RGC International Investments (maybe Investors),LDC. This was done through the management company Rose Glen Capital Group Inc. Again they said they knew of the down falls of this type of preferred before the agreement. The money will be used mostly to expand drug manufacturing facilities. Ribi sell the drugs they make and receive royalties on them. The phase III results of Ribi's adjuvant with herpes vaccine may be out in September. Maybe this is good because if we get good news on the adjuvant and melacine at about the same time it will help the stock price more. I have ISIP and they had their first drug (which will not have much revenue) approved last week and the stock is down now. Tom

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next